ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions
View by Date
Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
  • B Cell Deficiency Inhibits Both Antibody Mediated Rejection and T Cell Mediated Acute Rejection in a Rat Kidney Transplant Model.

    S. Panzer, S. Reese, N. Wilson Schlei, B. Verhoven, D. Xiang, W. Zhong, A. Djamali.

  • B Cell-Derived Cytokines Rather Than T/B Cognate Interactions Mediate CD8 T Cell Reconstitution Following Lymphoablation.

    D. Zwick, K. Ayasoufi, R. Fan, V. Gorbacheva, K. Keslar, R. Fairchild, A. Valujskikh.

  • B Cells in Liver Transplant Tolerance.

    M. Morita,1 G. Asonye,1 N. Gupta,1 J. Fung,2 C. Miller,3 S. Qian,1,3 L. Lu.1,3

  • Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes.

    S. Brar, Y. Wang, A. Cannitelli, Y. Li, O. Famure, S. Husain, J. Kim.

  • Banff 2013 Classification of Renal Allograft Pathology Is Superior to Banff 2007 in Detecting and Managing Milder and Earlier Cases of Antibody-Mediated Rejection.

    J. Hassler,1 V. Ariyamuthu,2 A. Hendricks,1 B. Tanriover,2 J. Torrealba.1

  • Bariatric Operations at a Service of the Transplant Surgery.

    A. Keidar,1 R. Yemini,1 M. Ben David,1 E. Nesher,2 J. Vinkler,3 M. Broun,2 E. Mor.2

  • Bariatric Surgery Prior to Living Kidney Donation: A Solution to Expand the Donor Pool.

    M.-T. Nguyen, D. Carpenter, A. Mathur, J. Van Bever, R. Sandoval, L. Ratner.

  • Barriers and Experiences When Patients Decide on a Kidney Transplant Center.

    C. Schaffhausen,1,4 M. Bruin,3 J. Synder,2,4 B. Kasiske,1,4 A. Israni.1,2,4

  • Barriers to Becoming Active on the Renal Transplant Waiting List: Have They Changed in the Last Five Years?

    E. van Hardeveld,1 T. Furlong,2 A. Robertson,2 N. Suh,2 S. Thwaites,2 R. Millar,2 R. Masterson,1 M. Lian,1 B. Jones,1 P. Hughes.1

  • Baseline Immune Assessment to Individualize Immunosuppression in SPK Recipients with Type 1 Diabetes.

    Y. Kudva, V. Dadlani, A. Miller, M. Abdallah, W. Kremers, M. Stegall, R. Abraham.

  • Belatacept After Kidney Transplantation in Adolescents.

    C. Lerch, N. Kanzeleyer, T. Ahlenstiel-Grunow, K. Froede, M. Kreuzer, J. Drube, L. Pape.

  • Belatacept Conversion for Calcineurin Inhibitor (CNI) Toxicity: Our First 100 Patients.

    R. Crew, S. Patel, A. Pai, I. Batal, H. Fernandez.

  • Belatacept Conversion in Kidney Recipients with Low GFR Does Not Improve Renal Function.

    D. Abdelwahab,1 S. Byron,2 B. Kaplan,1 R. Heilman.1

  • Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation.

    D. Kumar,1 G. Gupta,1 J. Reeve,2 P. Sanghi,1 S. Bobba,1 M. Levy,1 C. Bhati,1 P. Kimball,1 H. Fattah,1 A. King,1 H. Massey,1 P. Halloran.2

  • Belatacept in Chronic Kidney Disease Stabilizes and Improves Renal Function in Pancreas Transplant Recipients: Intermediate Results.

    J. Chen, M. Mujtaba, T. Taber, M. Yaqub, J. Powelson, O. Adebiyi, J. Fridell, A. Sharfuddin.

  • Beneficial Effects of Human Mesenchymal Stromal Cells on Porcine Hepatocytes Viability and Albumin Secretion.

    E. Montanari,1 J. Pimenta,1 H.-J. Schuurman,1 J. Meier,1 R. Meyer,1 A. Balaphas,1 J. Sidibé,2 A. Thomas,2 S. Passemard,3 S. Gerber-Lemaire,3 C. Gonelle-Gispert,1 L. Buhler.1

  • Beneficial Effects of Hydrogen Sulfide (H2S) on Renal Ischemia-Reperfusion Injury (IRI) in CLAWN Miniature Swine.

    Y. Ariyoshi, M. Sekijima, H. Sahara, T. Murokawa, A. Shimizu, K. Yamada.

  • Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function.

    J. Lee,1 J. Lee,1 J. Lee,2 S. Song,1 J. Lee,1 S.-K. Kwon,1 M. Kim,1 G. Choi,1 S. Kim,1 D. Joo.1

  • Benefits of Expanding Options for Patients Registered in the Kidney Paired Donation Program.

    S. Stepkowski, B. Mierzejewska, D. Belbolsynov, C. Baum, J. Kopke, R. Brunner, S. Rees, M. Rees.

  • Benefits of Induction in Recipients of Acute Renal Failure Donor Kidneys.

    M. Barrett, A. Smith, K. Woodside, R. Sung.

  • Benefits of Multimodal Enhanced Recovery Pathway in Patients Undergoing Kidney Transplantation.

    K. Espino,1 L. Kayler.2

  • Benefits of Mycophenolate Sodium Over Mycophenolate Mofetil in Renal Transplant Patients Carrying UGT1A9 Polymorphism.

    N. Calvo Romero, I. Perez-Flores, A. Shabaka, M. Moreno De La Higuera, B. Rodriguez-Cubillo, J. Delgado, M. Calvo, V. Lopez De La Manzanara, A. Sanchez-Fructuoso.

  • Beta Cell-Specific Free Circulating DNA May Predict the Outcome After Clinical Islet Transplantation.

    B. Gala-Lopez,1 D. Neiman,2 T. Kin,1 D. O'Gorman,1 A. Pepper,1 A. Malcolm,1 B. Glaser,3 R. Shemer,2 Y. Dor,2 J. Shapiro.1

  • Beyond the Bones – The Association Between Vitamin D, Graft Outcomes, Malignancy and Vascular Disease.

    A. Seitz,1 A. Cherukuri,2 R. Baker.1

  • Biliary Complications After Pediatric Liver Transplantation: A High Volume Living Donor Liver Transplantation Center Study of 237 Patients Over 27 Years.

    D. Oh,1 N.-J. Yi,1 S. Ahn,1 S. Hong,1 K. Yoon,1 H.-S. Kim,1 H. Kim,1 K.-W. Lee,1 K.-S. Suh,1 J. Han,2 M. Kim,2 J. Lee.2

  • Biliary Complications Following Liver Transplantation – Single-Center Experience Over Three Decades and Recent Risk Factors.

    A. Kaltenborn, A. Gutcke, H. Schrem, J. Gwiasda.

  • Biliary Complications in Pediatric Liver Transplantation for Cystic Fibrosis: A Single-Center Experience with Choledochocholedochostomy.

    P. Rizk, J. Moffett, M. Vu, R. Ackah, R. Sigireddi, M. Finegold, C. O'Mahony, A. Rana, J. Goss.

  • Binding of Antigens by Its Specific Antibodies Results in Exosome Formation Leading to Rejection of Syngeneic Murine Cardiac Grafts.

    M. Sharma, W. Liu, M. Gunasekaran, S. Bansal, T. Mohanakumar.

  • Binding of Human Neutrophils to Activated Porcine Endothelium Is Mediated by E-Selectin.

    C. Laird,1 B. French,1 L. Burdorf,1 X. Cheng,1 W. Fogler,2 J. Magnani,2 C. Phelps,3 D. Ayares,3 A. Azimzadeh,1 R. Pierson.1

  • Biodistribution of Adipose Derived Regenerative Cells Administered via the Renal Artery in Novel Rat Transplant Model.

    R. Ghita,1,2 R. Lathan,2 D. Hillyard,2 P. Mark,1,2 M. Clancy.1,2

  • Bioengineering Human Islets to Form Peri-Islet Vessels from Intraislet Endothelial Cells for Improving Human Islet Function.

    G. Loganathan, S. Narayanan, M. Dhanasekaran, A. Patel, W. Tucker, M. Hughes, S. Williams, A. Balamurugan.

  • Biological Interplay Between Circulating HLA-sp Alloreactive Memory B-Cells and Long-Lived Plasma Cells in Kidney Transplant Patients Undergoing Chronic ABMR.

    S. Luque,2 M. Lúcia,4 M. Jarque,2 E. Crespo,2 E. Melilli,1 J. Martorell,3 J. Cruzado,1,2 J. Torras,1,2 J. Grinyó,1,2 O. Bestard.1,2

  • Biomarkers of Epithelial-Mesenchymal Transition (EMT) in Chronic Allograft Nephropathy: Potential for Early Detection and Development of Novel Therapeutic Agents.

    S. Kanangat, R. Miller, S. Rezaeian, H. Eldib, D. Cimbaluk, C. Fhied, I. Kurbegovic-Skaljic, M. Prod, J. Borgia, M. Flaws, D. Castillo, R. DeCresce.

  • Biopsies (Bx) of Renal Allografts with Antibody- + Cell-Mediated Rejection (ABMR/CMR) Exhibit Gene Expression Signatures from Both Types of Rejection.

    H. Zhang,1 C. Nast,2 J. Doldron,2 M. Cheung,2 J. Mirocha,3 J. Kahwaji,1 A. Vo,1 S. Jordan,1 M. Toyoda.1

  • BK Polyoma Virus and Malignancy: Cause or Co-Incidence?

    R. Prashar, A. Shah, D. Stewart, S. Williamson, A. Patel.

  • BK Polyomavirus-Specific 9mer T-Cell Responses Predict Control of Viremia in Kidney Transplant Recipients: First Report from the Swiss Transplant Cohort Study.

    H. Hirsch,1 C. Leboeuf,1 S. Wilk,1 R. Achermann,2 I. Binet,3 D. Golshayan,2 K. Hadaya,2 C. Hirzel,2 M. Hoffmann,2 U. Huynh-Do,2 M. Koller,2 O. Manuel,2 N. Mueller,2 T. Mueller,2 S. Schaub,2 C. Van Delden,2 F. Weissbach.1

  • BK Viruria Levels within 3 Months Post Renal Transplantation Can Predict the Development of BK Viraemia.

    N. Lioufas,1 R. Masterson,1,2 P. Hughes.

  • BK Virus in Simultaneous Pancreas Kidney Transplantation.

    P. Uva,1,2 L. Leon,1 E. Minue,1 A. Dotta,1 F. Toniolo,1 R. Pilotti,1 E. Chuluyan,2 D. Casadei.1

  • BK Virus Infection and Risk of Urinary Tract Cancers Among Kidney Transplant Patients in the Transplant Cancer Match Study.

    G. Gupta,1 S. Kuppachi,2 R. Kalil,2 C. Buck,3 C. Lynch,2 E. Engels.3

  • BK Virus, Cytomegalovirus and Epstein-Barr Virus Reactivation in Renal Transplant Patients: Results from a Large Multicenter Study.

    A. Blázquez-Navarro,1 C. Dang-Heine,1 M. Or-Guil,2 C. Bauer,3 T. Westoff,4 C. Hugo,5 P. Reinke,1 B. Sawitzki,1 N. Babel.1,4

  • BKV Clearance Time Correlates with T-Cell Receptor Repertoire Shape and Exhaustion State of BKV-Specific T-Cells in Renal Transplant Patients with Severe BKV Infection.

    U. Stervbo,1,2 M. Nienen,1 B. Weist,2 P. Wehler,2 T. Westhoff,1 H.-D. Volk,2 P. Reinke,2 N. Babel.1,2

  • Blockade of Tim-3 and PD-1 Reverses Dysfunctions of Tumor Infiltrating Lymphocytes in HBV Related Hepatocellular Carcinoma.

    A. Hu, F. Liu, X. Zhu, X. He.

  • Blocked of Bat3 Expression Promotes Transplant Tolerance by Inducing IL-10 Expression in Dendritic Cells.

    G. Gu, H. Hang, Q. Xia.

  • Blood and Biopsy Genomic Signatures of Acute Rejection in Liver Transplant Recipients.

    J. Levitsky,1 T. Whisenant,2 S. Kurian,2 S. Rao,1 A. Demetris,3 M. Abecassis.1

  • Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome Appearance After Lung Transplantation.

    R. Danger,1 P. Royer,2 D. Reboulleau,2 J. Loy,2 A. Tissot,2 P. Lacoste,2 A. Roux,3 M. Reynaud-Gaubert,4 R. Kessler,5 S. Mussot,6 C. Dromer,7 O. Brugière,8 J. Mornex,9 R. Guillemain,10 M. Dahan,11 C. Knoop,12 K. Botturi,2 C. Pison,13 L. Nicod,14 S. Brouard,1 A. Magnan,2 COLT and SysCLAD Consortia.

  • Blood Tfh Cells Exhibit Impaired B Cell Help in Operationally Tolerant Patients.

    R. Danger,1 A. Chenouard,1 M. Chesneau,1 S. Castagnet,2 P. Guérif,1 N. Degauque,1 M. Giral,1 S. Brouard.1

  • Blood Transfusion Before Organ Transplant: Patient Sensitization and Outcomes.

    I. Cich, K. Rudser, R. Brown, H. Ibrahim, R. Thorson, J. Patil, G. Loor, M. Hertz, C. Cohn.

  • Blood Transfusion Induced Donor Specific Antibodies Are Associated with Rejection and Graft Failure.

    S. Hassan,1 F. Regan,2,3 C. Brown,4 A. Harmer,3 N. Anderson,3 P. Brookes,5 D. Taube,1 M. Willicombe.1

  • Bortezomib for Late Antibody-Mediated Rejection After Renal Transplantation: A Single Center Experience of 22 Cases.

    J. Choi, J. Jung, S. Chun, S. Shin, Y. Kim, D. Han.

  • Brain-Dead Donors Terminal Inflammation Is Associated to Delayed Graft Function in Kidney Transplant Recipients.

    D. Cucchiari,1 D. Fritz,2 V. Pedro,2 A. Ramon,3 P. David,3 R. Jordi,2 O. Frederic,2 R. Ignacio.2

  • Building a Conceptual Framework of Treatment Burden After Kidney Transplant: A Qualitative Study.

    E. Lorenz, J. Egginton, M. Stegall, A. Cheville, D. Eton.

  • Burden of Early Hospitalization Among Liver Transplant Recipients.

    P. Sharma,1 N. Goodrich,3 D. Schaubel,2 A. Smith,3 R. Merion.3,4

Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2023 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences